Literature DB >> 26084209

US trends in survival disparities among adolescents and young adults with non-Hodgkin lymphoma.

Erin E Kent1, Nancy Breen, Denise R Lewis, Janet S de Moor, Ashley Wilder Smith, Nita L Seibel.   

Abstract

PURPOSE: Improvement in US survival rates among adolescents and young adults (AYAs, ages 15 through 39 years inclusive) diagnosed with non-Hodgkin lymphoma (NHL) has been documented over the last two decades. We examined national trends in survival disparities for AYAs with NHL by race/ethnicity and socioeconomic status (SES, county-level poverty) to further understand NHL and to begin monitoring health outcome disparities for this disease.
METHODS: Surveillance Epidemiology and End Results data were used to calculate 5-year relative survival rates of AYAs diagnosed with NHL from 1992 to 2007 and followed through 2011. Absolute and relative disparities were computed using HD*Calc. Whether a significant linear trend was present was evaluated using Joinpoint. Analyses were replicated after excluding individuals with known HIV infection.
RESULTS: The study sample included 9,573 total and 7,121 non-HIV cases of NHL. Five-year survival rates improved for all groups over time. Significant decreases were found in absolute disparities for race/ethnicity (non-HIV), in relative disparities for SES (total) and race/ethnicity (total and non-HIV) (all p < 0.05). Survival rates of non-Hispanic Blacks and Hispanics remained below than those of non-Hispanic Whites throughout the time period.
CONCLUSION: Absolute and relative disparities in 5-year survival narrowed for AYAs with NHL over the time period. To continue to promote this trend, future research should investigate factors, particularly diagnostic delays and barriers to care, which continue to contribute to SES and racial/ethnic differences in survival. These factors may be particularly relevant to identify given the recent Affordable Care Act, which is designed to increase access to medical services, particularly for young adults.

Entities:  

Mesh:

Year:  2015        PMID: 26084209      PMCID: PMC4556271          DOI: 10.1007/s10552-015-0609-1

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  26 in total

1.  Racial differences in three major NHL subtypes: descriptive epidemiology.

Authors:  Yang Li; Yu Wang; Zhuoyue Wang; Danhui Yi; Shuangge Ma
Journal:  Cancer Epidemiol       Date:  2015-01-02       Impact factor: 2.984

2.  Health disparities calculator: a methodologically rigorous tool for analyzing inequalities in population health.

Authors:  Nancy Breen; Susan Scott; Antoinette Percy-Laurry; Denise Lewis; Russell Glasgow
Journal:  Am J Public Health       Date:  2014-07-17       Impact factor: 9.308

3.  Medical care in adolescents and young adult cancer survivors: what are the biggest access-related barriers?

Authors:  Theresa H M Keegan; Li Tao; Mindy C DeRouen; Xiao-Cheng Wu; Pinki Prasad; Charles F Lynch; Margarett Shnorhavorian; Brad J Zebrack; Roland Chu; Linda C Harlan; Ashley W Smith; Helen M Parsons
Journal:  J Cancer Surviv       Date:  2014-01-10       Impact factor: 4.442

4.  Patterns of care in a population-based random sample of patients diagnosed with non-Hodgkin's lymphoma.

Authors:  Deirdre P Cronin; Linda C Harlan; Limin X Clegg; Jennifer L Stevens; Gigi Yuan; Thomas A Davis
Journal:  Hematol Oncol       Date:  2005-06       Impact factor: 5.271

5.  Outcome of diffuse large B-Cell lymphoma in the United States has improved over time but racial disparities remain: review of SEER data.

Authors:  Rami S Komrokji; Najla H Al Ali; M S Beg; Malek M Safa; Dana Rollison; Mohamed Kharfan-Dabaja; Celeste Bello; Jennifer Cultrera; Lubomir Sokol; Javier Pinilla-Ibarz; Eduardo M Sotomayor
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2011-04-20

6.  Racial disparity in U.S. diagnoses of acquired immune deficiency syndrome, 2000-2009.

Authors:  Qian An; Joseph Prejean; H Irene Hall
Journal:  Am J Prev Med       Date:  2012-11       Impact factor: 5.043

7.  Trends in survival after diagnosis with hematologic malignancy in adolescence or young adulthood in the United States, 1981-2005.

Authors:  Dianne Pulte; Adam Gondos; Hermann Brenner
Journal:  Cancer       Date:  2009-11-01       Impact factor: 6.860

8.  Cancer-specific outcomes among young adults without health insurance.

Authors:  Ayal A Aizer; Benjamin Falit; Mallika L Mendu; Ming-Hui Chen; Toni K Choueiri; Karen E Hoffman; Jim C Hu; Neil E Martin; Quoc-Dien Trinh; Brian M Alexander; Paul L Nguyen
Journal:  J Clin Oncol       Date:  2014-06-02       Impact factor: 44.544

9.  Rituximab use and survival after diffuse large B-cell or follicular lymphoma: a population-based study.

Authors:  Theresa H M Keegan; Lisa M Moy; James M Foran; Ash A Alizadeh; Ellen T Chang; Sarah J Shema; Clayton W Schupp; Christina A Clarke; Sally L Glaser
Journal:  Leuk Lymphoma       Date:  2012-09-28

10.  Socioeconomic Impacts on Survival Differ by Race/Ethnicity among Adolescents and Young Adults with Non-Hodgkin's Lymphoma.

Authors:  Erin E Kent; Rebecca A Morris; Joan A Largent; Argyrios Ziogas; Leonard S Sender; Hoda Anton-Culver
Journal:  J Cancer Epidemiol       Date:  2010-06-22
View more
  8 in total

1.  Does socioeconomic status account for racial and ethnic disparities in childhood cancer survival?

Authors:  Rebecca D Kehm; Logan G Spector; Jenny N Poynter; David M Vock; Sean F Altekruse; Theresa L Osypuk
Journal:  Cancer       Date:  2018-08-20       Impact factor: 6.860

2.  Racial and ethnic differences in all-cause mortality among Hispanics diagnosed with follicular lymphoma and chronic lymphocytic leukemia in the Bronx, NY.

Authors:  Deanna Blansky; Melissa Fazzari; Ioannis Mantzaris; Thomas Rohan; H Dean Hosgood
Journal:  Cancer Causes Control       Date:  2021-10-22       Impact factor: 2.532

3.  Association of socioeconomic status with autologous hematopoietic cell transplantation outcomes for lymphoma.

Authors:  S Hong; L Rybicki; D M Abounader; B J Bolwell; R Dean; A T Gerds; B K Hamilton; B T Hill; D Jagadeesh; M Kalaycio; H D Liu; B Pohlman; R Sobecks; N S Majhail
Journal:  Bone Marrow Transplant       Date:  2016-04-25       Impact factor: 5.483

4.  Affluence and Private Health Insurance Influence Treatment and Survival in Non-Hodgkin's Lymphoma.

Authors:  Harry Comber; Marianna De Camargo Cancela; Trutz Haase; Howard Johnson; Linda Sharp; Jonathan Pratschke
Journal:  PLoS One       Date:  2016-12-19       Impact factor: 3.240

5.  Outcome of HIV-associated lymphoma in a resource-limited setting of Jos, Nigeria.

Authors:  Olugbenga Akindele Silas; Chad J Achenbach; Lifang Hou; Robert L Murphy; Julie O Egesie; Solomon A Sagay; Oche O Agbaji; Patricia E Agaba; Jonah Musa; Agabus N Manasseh; Ezra D Jatau; Ayuba M Dauda; Maxwell O Akanbi; Barnabas M Mandong
Journal:  Infect Agent Cancer       Date:  2017-06-05       Impact factor: 2.965

6.  Emerging Cancer Survival Trends, Disparities, and Priorities in Adolescents and Young Adults: A California Cancer Registry-Based Study.

Authors:  Diana J Moke; Kaiya Tsai; Ann S Hamilton; Amie Hwang; Lihua Liu; David R Freyer; Dennis Deapen
Journal:  JNCI Cancer Spectr       Date:  2019-06-12

7.  Time and spatial trends in lymphoid leukemia and lymphoma incidence and survival among children and adolescents in Manitoba, Canada: 1984-2013.

Authors:  Xibiao Ye; Mahmoud Torabi; Lisa M Lix; Salaheddin M Mahmud
Journal:  PLoS One       Date:  2017-04-21       Impact factor: 3.240

8.  Disparities by race, age, and sex in the improvement of survival for lymphoma: Findings from a population-based study.

Authors:  Fahad Mukhtar; Paolo Boffetta; Bashir Dabo; Jong Y Park; Chi T D Tran; Thuan V Tran; Huong Thi-Thanh Tran; Madison Whitney; Harvey A Risch; Linh C Le; Wei Zheng; Xiao-Ou Shu; Hung N Luu
Journal:  PLoS One       Date:  2018-07-11       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.